grey market glp 1 GLP-1 now considered on the Explainer: The Thriving Shadow Market

In April 2025, Pfizer Inc

Lawrence, D

Please talk with your doctor about the risks and side effects before starting any GLP-1 medication

Possible Side Effects Ipamorelin is generally well-tolerated in preclinical and limited human research studies, with a favorable safety profile compared to earlier growth hormone releasing peptides

However, current findings are limited mainly to chemical compositional analyses, and practical parameters such as sensory acceptance, consumer satisfaction, and product stability are not adequately addressed

The aim of the present narrative review is to provide an integrative synthesis centered on melatonin, examining how its age-related decline mechanistically connects circadian disruption, sleep impairment, chrononutritional factors, and antioxidant defenses